io.github.simonmak-ascent/startup-valuation · v2.1.3 · finance-and-payments
Startup Valuation MCP Server is healthy: it completed an MCP handshake in 2882 ms and exposes 14 tools.
Startup valuation for AI agents: 14 tools, 80+ pre-revenue formulas.
Endpoint: https://startup-valuation.ascent-partners.com/api (streamable-http)
Repository · Website · JSON · Add to my inventory
| Users (last 30 days) | 0 |
| Handshake | Healthy |
| Auth needed | None |
| Tool count | 14 |
| Latency | 2882 ms |
| Last checked (UTC) | 2026-10-15T10:40:15.522Z |
| Checked (UTC) | Status | Latency | Error |
|---|---|---|---|
| 2026-10-15T10:40:15.522Z | Healthy | 2882 |
valuation_probability | Compute expected value and probability-weighted outcomes for startup scenarios: discrete E[X], joint probability of sequential events, probability-weighted value, VC portfolio expected return, Poisson event probability, and continuous E[X] over a range. Method selects the formula. Use for probabilit |
valuation_time_value | Discount, compound, and forecast value over time: single future value PV, net present value of a cash-flow stream, annuity present value, discounted cash flow with a Gordon terminal value, constant-rate compound growth of revenue or cash flow, and the implied compound annual growth rate (CAGR). Meth |
valuation_capm | Estimate the cost of capital: standard CAPM, startup-adjusted CAPM with size and illiquidity premiums, portfolio beta from weighted asset betas, and WACC blending after-tax cost of equity and debt. Method selects the formula. Use to derive the discount rate that feeds valuation_time_value and DCF mo |
valuation_core | The textbook's pre-revenue methods: Scorecard, Berkus, Risk-Factor Summation, VC Method (post- and pre-money), and exit terminal value. Use these first for early-stage startups. Method selects the formula, and each method names its own parameters: scorecard needs average_valuation + weights + scores |
valuation_advanced | Advanced techniques: Black-Scholes call value, binomial-tree option value, and scenario analysis. Method selects the technique. For a quick expected value over arbitrary outcome lists, prefer valuation_probability with method 'probability_weighted'; scenario_analysis here is for explicit named bull/ |
valuation_comparables | Market multiples from comparables: P/E, P/S, EV/EBITDA, EV/Revenue, and a regression-adjusted multiple. Method selects the ratio. Use when public comparables exist; for pre-revenue or private startups use valuation_core. Parameters apply per method: pe_ratio needs market_cap + net_income; ps_ratio n |
valuation_saas | SaaS unit economics and valuation: LTV, CAC, MRR, ARR, net revenue retention, magic number, Rule of 40, CAC payback, and ARR revenue-multiple valuation. Method selects the metric. Use for subscription software; for marketplace GMV metrics use valuation_marketplace and for payments/lending use valuat |
valuation_marketplace | Marketplace health and valuation: take rate, GMV revenue-multiple valuation, buyer retention, and network density. Method selects the metric. Use for two-sided transaction marketplaces; for subscription software use valuation_saas. Parameters apply per method: take_rate needs revenue + gmv; gmv_mult |
valuation_fintech | Value and size fintech business models: payment revenue, lending valuation, payment-processor DCF, and neobank customer-based valuation. Method selects the model. Use for payments, lending, and neobanks; for SaaS-style unit economics use valuation_saas. Parameters apply per method: payment_revenue n |
valuation_biotech | Risk-adjusted biotech valuation: peak sales, decision-tree expected value, and full pipeline rNPV across drugs. Method selects the model. Use for pharma/drug pipelines; for hardware or deep tech use valuation_hardware. Parameters apply per method: peak_sales needs patient_population + penetration + |
valuation_hardware | Hardware and deep-tech valuation: TRL-risk-adjusted valuation, gross margin, and break-even volume. Method selects the metric. Use for hardware and deep tech with technology-readiness risk; for drug pipelines use valuation_biotech. Parameters apply per method: trl needs market_size + market_share + |
valuation_international | Cross-border adjustments: purchasing-power parity, country risk premium, and international CAPM. Method selects the adjustment. Use for cross-border cash flows and country risk; pair with valuation_capm and valuation_time_value. Parameters apply per method: ppp needs spot_rate + inflation_foreign + |
valuation_stakeholder | Allocate value across stakeholders and equity classes: single-round dilution, OPM common stock, PWERM, liquidation value, M&A synergy, employee-option values, vesting adjustment, cash-vs-equity break-even, and asset-based loan capacity. Method selects the model. Use only after the company-level valu |
valuation_emerging | Modern and alternative valuation: SAFE conversion (discount, cap, expected value), token valuation (equation of exchange, NVT), ESG adjustments (rate, premium, discount), Metcalfe network value, data-moat value, and remote-first premium/NPV. Method selects the model. Use for SAFEs, tokens, ESG, netw |